Neeraj G. Patel
Doctor of Medicine Candidate, Yale School of MedicineAbout
Research
Publications
2026
Internet Searches for Leucovorin, Folate, and Acetaminophen After a White House Autism Announcement
Patel N, Ramachandran R, Ross J. Internet Searches for Leucovorin, Folate, and Acetaminophen After a White House Autism Announcement. JAMA Network Open 2026, 9: e2617910. PMID: 42275066, PMCID: PMC13261488, DOI: 10.1001/jamanetworkopen.2026.17910.Peer-Reviewed Original ResearchAdvertising Payments to News Websites That Publish Health Misinformation
Patel N, Ramachandran R, Ross J. Advertising Payments to News Websites That Publish Health Misinformation. JAMA Network Open 2026, 9: e265068. PMID: 41920545, PMCID: PMC13044671, DOI: 10.1001/jamanetworkopen.2026.5068.Peer-Reviewed Original Research
2025
Changes in pharmaceutical industry payments to physicians after New Jersey's 2018 restriction
Patel N, Ramachandran R, Ross J. Changes in pharmaceutical industry payments to physicians after New Jersey's 2018 restriction. Health Affairs Scholar 2025, 4: qxaf254. PMID: 41536639, PMCID: PMC12798812, DOI: 10.1093/haschl/qxaf254.Peer-Reviewed Original Research
2024
US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion
Patel N, Mohammad A, Ross J, Ramachandran R. US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion. The BMJ 2024, 384: e076138. PMID: 38383007, DOI: 10.1136/bmj-2023-076138.Peer-Reviewed Original Research
2023
Trust and Regulation: Assuring Scientific Independence in the FDA’s Emergency Use Authorization Process
Patel N, Kesselheim A, Darrow J. Trust and Regulation: Assuring Scientific Independence in the FDA’s Emergency Use Authorization Process. Journal Of Health Politics Policy And Law 2023, 48: 799-820. PMID: 36995365, DOI: 10.1215/03616878-10637726.Peer-Reviewed Original ResearchConceptsUS government officialsDemocratic accountabilityAgency decision-making processesAgency independenceGovernment leadersGovernment officialsPolitical pressureUS AgencyPublic trustPublic confidenceDecision-makingPublic health regulationsDecision-making processGovernmentReformAgenciesScientific independenceCOVID-19 pandemicIndependenceAccountsHealth RegulationsTrustSource of inspirationOfficialsScience-based decision-makingTherapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021
. Therapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021. JAMA Network Open 2023, 6: e2250991. PMID: 36637824, PMCID: PMC9857401, DOI: 10.1001/jamanetworkopen.2022.50991.Peer-Reviewed Original Research
2022
Using Multiple Authorized Generics to Maintain High Prices: The Example of Entacapone
Rome B, Egilman A, Patel N, Kesselheim A. Using Multiple Authorized Generics to Maintain High Prices: The Example of Entacapone. Value In Health 2022, 26: 370-377. PMID: 36266218, DOI: 10.1016/j.jval.2022.08.013.Peer-Reviewed Original ResearchConceptsBrand-name manufacturersBrand-name drug manufacturersLegal historyCourt recordsSettlement AgreementGeneric competitionAuthorized genericsGovernment regulationDrug manufacturersMedicare pricesPublic foodActual spendingMedicare Part D dataPart D dataCourtGenericsLicenseHigher pricesCompetitionSpendingGovernmentSettlementPrice declinesMedicareAgreementThe $5 Billion Hop: Glatiramer Acetate and the US Patent System.
. The $5 Billion Hop: Glatiramer Acetate and the US Patent System. The Journal Of Law, Medicine & Ethics 2022, 50: 852-856. PMID: 36883396, DOI: 10.1017/jme.2023.27.Peer-Reviewed Original Research
2020
False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications
Woloshin S, Kesselheim A, Patel N. False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications. The New England Journal Of Medicine 2020, 383: e38. PMID: 32502334, DOI: 10.1056/nejmp2015897.Peer-Reviewed Original Research